Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Paul, Subarno  [Clear All Filters]
2024
Dash SRanjan, Das C, Das B, Jena ABihari, Paul S, Sinha S, Tripathy J, Kundu CNath. Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells. Nanomedicine (Lond). 2024.
2023
Das B, Sethy C, Chatterjee S, Dash SRanjan, Sinha S, Paul S, Goutam K, Kundu CNath. Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells. J Cell Commun Signal. 2023.
Das C, Dash SRanjan, Sinha S, Paul S, Das B, Bhal S, Sethy C, Kundu CNath. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300. Med Oncol. 2023;40(12):351.
Paul S, Chatterjee S, Sinha S, Dash SRanjan, Pradhan R, Das B, Goutam K, Kundu CNath. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells. Expert Opin Ther Targets. 2023.
2022
Pradhan R, Paul S, Das B, Sinha S, Dash SRanjan, Mandal M, Kundu CNath. Resveratrol Nanoparticle attenuates metastasis and angiogenesis by deregulating inflammatory cytokines through inhibition of CAFs in oral cancer by CXCL-12/IL-6 dependent pathway. J Nutr Biochem. 2022:109257.
Paul S, Sinha S, Kundu CNath. Targeting cancer stem cells in the tumor microenvironment: An emerging role of PARP inhibitors. Pharmacol Res. 2022:106425.
2021
Dash SRanjan, Chatterjee S, Sinha S, Das B, Paul S, Pradhan R, Sethy C, Panda R, Tripathy J, Kundu CNath. NIR irradiation enhances the apoptotic potentiality of Quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells. Nanomedicine. 2021:102502.